CoChat
Sign Up
Cited by 283

Plasma processing conditions substantially influence circulating microRNA biomarker levels

Cheng, Heather H., Yi, Hye Son, Kim, Yeonju, Kroh, Evan M., Chien, Jason W., Eaton, Keith D., Goodman, Marc T., Tait, Jonathan F. +2 more·2013·PLoS ONE
DOI 10.1371/journal.pone.0064795PMC PMC3676411
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0064795

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Most plasma miRNAs were RBC derived, followed by platelets, mesenchymal cells, and immune cells.

    “Similar to a recent manuscript on cell-free RNA in plasma [40] and consistent with other miRNA-based studies [41–43], we observed that most plasma miRNAs were RBC derived, followed by platelets, mesenchymal cells, and immune cells.”

    From A curated human cellular microRNAome based on 196 primary cell types (2022) · cites this paper as [42]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 27

  1. [1]Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513– 10518. 18663219 PMC2492472
  2. [2]Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, et al (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672– 675. 18318758
  3. [3]Chen X, Ba Y, Ma L, Cai X, Yin Y, et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997– 1006. 18766170
  4. [4]Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, et al (2011) MicroRNAs in body fluids–the mix of hormones and biomarkers. Nat Rev Clin Oncol 8: 467– 477. 21647195 PMC3423224
  5. [5]Mostert B, Sieuwerts AM, Martens JW, Sleijfer S (2011) Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients. Expert Rev Mol Diagn 11: 259– 275. 21463236
  6. [6]Dancey JE, Dobbin KK, Groshen S, Jessup JM, Hruszkewycz AH, et al (2010) Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents. Clin Cancer Res 16: 1745– 1755. 20215558
  7. [7]Zhao X, Qureshi F, Eastman PS, Manning WC, Alexander C, et al (2012) Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis. J Immunol Methods 378: 72– 80. 22366959 PMC3404505
  8. [8]McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833– 840. 21487102
  9. [9]Duttagupta R, Jiang R, Gollub J, Getts RC, Jones KW (2011) Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 6: e20769. 21698099 PMC3117799
  10. [10]Kim DJ, Linnstaedt S, Palma J, Park JC, Ntrivalas E, et al (2012) Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn 14: 71– 80. 22154918 PMC3338348
  11. [12]Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, et al (2011) Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 117: 5189– 5197. 21415270 PMC3109541
  12. [13]Osman A, Falker K (2011) Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 22: 433– 441. 21438667
  13. [14]Simak J, Gelderman MP (2006) Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20: 1– 26. 16373184
  14. [15]Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, et al (2007) Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix. Cancer Res 67: 5987– 5996. 17553901
  15. [16]Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298– 301. 20146939 PMC4186708
  16. [17]Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116– 5121. 11309499 PMC33173
  17. [18]Wang L, Tang H, Thayanithy V, Subramanian S, Oberg AL, et al (2009) Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res 69: 9490– 9497. 19996289 PMC2795036
  18. [19]Aoe K, Hiraki A, Ueoka H, Kiura K, Tabata M, et al (2004) Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration 71: 170– 173. 15031573
  19. [20]Tomita M, Shimizu T, Hara M, Ayabe T, Onitsuka T (2008) Prognostic impact of thrombocytosis in resectable non-small cell lung cancer. Interact Cardiovasc Thorac Surg 7: 613– 615. 18502783
  20. [21]Pedersen LM, Milman N (1996) Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9: 1826– 1830. 8880098
  21. [22]Hastings ML, Palma J, Duelli DM (2012) Sensitive PCR-based quantitation of cell-free circulating microRNAs. Methods. PMC3508311 22884953
  22. [23]Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, et al (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102: 1174– 1179. 20234369 PMC2853097
  23. [24]Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499– 505. 20134314
  24. [25]Zeng X, Xiang J, Wu M, Xiong W, Tang H, et al (2012) Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS One 7: e46367. 23056289 PMC3466268
  25. [26]Xu J, Wu C, Che X, Wang L, Yu D, et al (2011) Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 50: 136– 142. 21229610
  26. [27]de Boer HC, van Solingen C, Prins J, Duijs JM, Huisman MV, et al.. (2013) Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J. 23386708
  27. [28]Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, et al (2013) Circulating MicroRNAs as Novel Biomarkers for Platelet Activation. Circ Res 112: 595– 600. 23283721

Cited by

Sorted by citations

Authors
Cheng, H. H., Yi, H. S., Kim, Y., Kroh, E. M., Chien, J. W., Eaton, K. D., Goodman, M. T., Tait, J. F., Tewari, M., & Pritchard, C. C.
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2013-06-07
Volume
8
Issue
6
Pages
e64795
ISSN
1932-6203
DOI
10.1371/journal.pone.0064795
PMC
PMC3676411
Cited by
283
References
1
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review